0
AMACR shows 90 percent sensitivity and 91 percent specificity for prostate cancer diagnosis.
Study included 37 analyses with 5,898 samples.
IHC provided superior diagnostic accuracy over RT-PCR methods.
Geographic variability impacts diagnostic performance.
Standardized protocols are necessary for non-invasive specimens.
